Comparison of the Effects of Green Exercise Programs on Metabolic Syndrome Parameters in Elderly Individuals

Metabolic Syndrome Clinical Trial

Official title:

Comparison of the Effects of Green Exercise Programs Including Resistance Exercises and Aerobic Exercises on Metabolic Syndrome Parameters in Elderly Individuals

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT05251597
• Other study ID #: Green exercise
• Status: Recruiting
• Phase: N/A
• Start date: March 27, 2022
• Est. completion date: November 12, 2022

Study information

• Verified date: March 2022
• Source: Istanbul Medeniyet University
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The aim of this study is to compare the effects of exercise programs that only aerobic exercise and combination aerobic exercise and resistance exercises on the metabolic syndrome parameters in the green exercise concept.

Description:

One hundred twenty volunteer participants aged 65 years over will be included in the study. Participants will be randomly divided into three groups as aerobic, aerobic and resistance and control group. While a group will receive only aerobic exercise, the other group group will receive both aerobic and resistance exercises and one of the group will receive no exercise. Exercises will be held in an open and green area. At the beginning of the treatment and at the end of the twelfth week Hemoglobin A1c (HbA1c), Triglyceride, Hdl cholesterol, Ldl cholesterol, total cholesterol and blood glucose will be evaluated.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 120
• Est. completion date: November 12, 2022
• Est. primary completion date: October 8, 2022
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 65 Years to 85 Years

Eligibility

Inclusion Criteria:

• people aged over 65 years

• Be fit to participate in exercise program after the first cardiac examination by the physician

• Individuals whose blood lipids, Hg a1c and glucose values were checked within 3 months

• According to the International Physical Activity Assessment Questionnaire, those who are physically inactive

• Having a score above 24 in the Minimental Test

Exclusion Criteria:

• Having neuromuscular disease

• Serious medical condition (for example, advanced malignancy or major neurological, psychiatric or endocrine disease, respiratory failure, etc.)

• Having an orthopedic disease that interferes with walking

• Having a score below 24 in the Minimental Test

Related Conditions & MeSH terms

• Metabolic Syndrome
• Syndrome

Intervention

Other:
• green exercise with aerobic exercise
Green exercise is a type of exercise done outdoors. It is an advantageous type of exercise in benefiting from sunlight and reducing anxiety. It is mostly applied in the form of brisk walking in the open air.

Locations

Country	Name	City	State
Turkey	Emel Mete	Istanbul
Turkey	Istanbul Medeniyet University	Istanbul

Sponsors (1)

Lead Sponsor	Collaborator
Istanbul Medeniyet University

Country where clinical trial is conducted

Turkey, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	physical activity level	physical activity level will be evaulated with international physical activity questionnairre (IPAQ). The questionnaire is based on calculating the MET (metabolic equivalent) value spent by evaluating at least 10 minutes of physical activity in the last seven days in terms of frequency, duration (minutes) and intensity. According to this questionnaire, physical activity level is categorized into 4 classes: inactive, not active enough, active, very active.	Change from baseline physical activity level at week 12.
Primary	blood pressure	Systolic and diastolic blood pressure will be measured using a standard semi-automatic sphygmomanometer.	Change from baseline blood pressure at week 12.
Primary	hemoglobin A1c	After 12-14 hr of fasting, a 10 cc blood sample will be collected from each participant. HbA1c will be measured using the Chromatography method with a com-mercial kit .	Change from baseline hemoglobin A1c at week 12.
Primary	lipid profile	HDL cholesterol, LDL cholesterol, total cholesterol and triglyceride serum levels will be measured to evaluate the lipid profile.HDL cholesterol, LDL cholesterol, total cholesterol and triglyceride will be assessed using enzymatic colorimetry with commercial kits.	Change from baseline lipid profile at week 12.
Primary	fasting blood glucose	After 12-14 hr of fasting, a 10 cc blood sample will be collected from each participant. Fasting blood samples from the antecubital vein will be collected by vacuum tubes. For biochemical analysis, Fasting blood glucose will be assessed with a commercial kit.	Change from baseline fasting blood glucose at week 12.